SCHEMBL29786263

SCHEMBL29786263

COc1ccc(Cn2cnc(-c3ccccc3Br)c2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 1/20 0.48
CDK5R1 Q15078 1/20 0.48
KDM4C Q9H3R0 1/20 0.44
KDM5B Q9UGL1 1/20 0.44
LMNA P02545 2/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
TSHR P16473 1/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HSP90AA1 P07900 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CASP3 P42574 1/20 0.41
HPGDS O60760 1/20 0.41
CYP19A1 P11511 1/20 0.41
SIGMAR1 Q99720 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23124130 1.00 CDK5 (0.48) CDK5CDK5R1KDM4CKDM5BLMNA
SCHEMBL4840104 0.81 HPGDS (0.58) CDK5CDK5R1KDM4CKDM5BLMNA
SCHEMBL29786346 0.80 KDM4C (0.48) CDK5CDK5R1KDM4CKDM5BHSP90AA1
SCHEMBL23123907 0.80 KDM4C (0.48) CDK5CDK5R1KDM4CKDM5BHSP90AA1
SCHEMBL5761329 0.79 CYP11B1 (0.54) CDK5CDK5R1KDM4CKDM5BLMNA
SCHEMBL5755079 0.79 NPC1 (0.60) CDK5CDK5R1LMNAMEN1KMT2A
SCHEMBL7510401 0.78 CDK5 (0.50) CDK5CDK5R1KDM4CKDM5BLMNA
SCHEMBL23123527 0.76 HTR1A (0.43) CDK5CDK5R1KDM4CKDM5BMEN1
SCHEMBL23123924 0.76 DRD2 (0.44) CDK5CDK5R1KDM4CKDM5B
SCHEMBL5757721 0.75 CLK1 (0.50) CDK5CDK5R1KDM4CKDM5BLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114787135-A Substituted imidazole carboxamides and their use in the treatment of medical disorders 比亚尔R&D投资股份公司 2022-07-22 CN disclosed